[go: up one dir, main page]

Srivastava et al., 2019 - Google Patents

Technetium-labeled compounds

Srivastava et al., 2019

Document ID
6552309013310309993
Author
Srivastava S
Richards P
Publication year
Publication venue
Radiotracers for Medical Applications

External Links

Snippet

This chapter summarizes the chemistry and the applications of technetium-labeled compounds, and highlights the advances in the field and future trends. The importance of technetium-99m in nuclear medicine continues to grow despite a poor understanding of its …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features

Similar Documents

Publication Publication Date Title
Srivastava et al. Technetium-labeled compounds
Vanderheyden et al. Comparison of the chemical and biological properties of trans-[Tc (DMPE) 2Cl2]+ and trans-[Re (DMPE) 2Cl2]+, where DMPE= 1, 2-bis (dimethylphosphino) ethane. Single-crystal structural analysis of trans-[Re (DMPE) 2Cl2] PF6
Deutsch et al. Technetium chemistry and technetium radiopharmaceuticals
EP0038756B1 (en) Cationic lipophilic complexes of 99m tc useful for myocardial and hepatobiliary imaging
Jurisson et al. Coordination compounds in nuclear medicine
Deutsch et al. Recent advances in technetium chemistry: bridging inorganic chemistry and nuclear medicine
Randhawa et al. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Kovács Theoretical study of actinide complexes with macropa
Srivastava et al. The development and in-vivo behavior of tin containing radiopharmaceuticals—I. Chemistry, preparation, and biodistribution in small animals
Steigman et al. Chemistry of technetium 99m
Hambright et al. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc
Venkatesh et al. Complexation studies with 90Y from a novel 90Sr-90Y generator
Richards et al. Chemistry of technetium as it is applied to radiopharmaceuticals
Moore et al. Zirconium molybdate gel as a generator for technetium-99m—II. High activity generators
Vágner et al. Equilibrium thermodynamics, formation, and dissociation kinetics of trivalent iron and gallium complexes of triazacyclononane-triphosphinate (TRAP) chelators: unraveling the foundations of highly selective Ga-68 labeling
Srivastava et al. Radioruthenium-labeled compounds for diagnostic tumor imaging
Harriswangler et al. Improving the in vivo Stability of [52Mn] mn (II) complexes with 18-Membered Macrocyclic Chelators for PET Imaging
Tisato et al. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals
Saha Radiopharmaceuticals and general methods of radiolabeling
Spies et al. Stannous chloride in the preparation of 99mTc pharmaceuticals
Clarke et al. The chemistry of technetium: Toward improved diagnostic agents
Boyd The special position of 99mTc in nuclear medicine
Arman et al. Separation of terbium as a first step towards high purity terbium-161 for medical applications
Saha Radiopharmaceuticals and methods of radiolabeling
Lacerda et al. Chemical, radiochemical and biological studies of Sm and Ho complexes of H4dota analogues containing one methylphosphonic/phosphinic acid pendant arm